ISMP (US) Contact Us Feedback
     Search:  
   

ISMP Canada News

May 18, 2017: Health Canada: Health Product Risk Communication for MIFEGYMISO (mifepristone & misoprostol tablets)


Health Canada: Health Product Risk Communication for MIFEGYMISO (mifepristone & misoprostol tablets)" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/286/" />

Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.